No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Animals
-
Cardiovascular Agents / administration & dosage
-
Cardiovascular Agents / therapeutic use*
-
Carotid Stenosis / drug therapy*
-
Carotid Stenosis / enzymology
-
Carotid Stenosis / pathology
-
Cell Proliferation / drug effects
-
Coronary Restenosis / enzymology
-
Coronary Restenosis / pathology
-
Coronary Restenosis / prevention & control*
-
Drug-Eluting Stents
-
Enzyme Activation
-
Enzyme Activators / administration & dosage
-
Enzyme Activators / therapeutic use*
-
Humans
-
Hyperplasia
-
Muscle, Smooth, Vascular / drug effects*
-
Muscle, Smooth, Vascular / enzymology
-
Muscle, Smooth, Vascular / pathology
-
NAD(P)H Dehydrogenase (Quinone) / antagonists & inhibitors
-
NAD(P)H Dehydrogenase (Quinone) / genetics
-
NAD(P)H Dehydrogenase (Quinone) / metabolism*
-
Naphthoquinones / administration & dosage
-
Naphthoquinones / therapeutic use*
-
Secondary Prevention
-
Tunica Intima / drug effects
-
Tunica Intima / enzymology
-
Tunica Intima / pathology
Substances
-
Cardiovascular Agents
-
Enzyme Activators
-
Naphthoquinones
-
beta-lapachone
-
NAD(P)H Dehydrogenase (Quinone)
-
NQO1 protein, human
-
NQO1 protein, rat